The presentation of uveitis is variable based on the location of the pathology. Patients with more anterior symptoms will have a more impressive exam while patients with predominantly posterior symptoms may only present with vision loss.
Most uveitis is unexplained. We are good at describing it, reasonable at classifying it, moderate at treating it and, as yet, terrible at understanding it. In our research we probably get closest to what is going on through taking precious fluid samples from the front of the inflamed eye.
Anterior uveitis can be acute or chronic, and the acute form is the most common form of uveitis. Posterior uveitis, affecting the retina and choroid, and intermediate uveitis, affecting the vitreous body, are less common.2 Uveitis can be classified by location, clinical course or side affected.
Uveitis can be a difficult diagnosis to understand at first given the multitude of different etiologies which can cause it. Don’t worry though; this pathology framework will provide the absolute essentials necessary to work through most uveitis cases in clinic.
Infectious uveitis accounts for majority of the cases of uveitis in developing countries. It also encompasses an array of various microorganisms and their clinical presentations. Some of these infectious uveitic entities are familiar, while others are newly emerging in the global ophthalmic world.
As a ûknow it all” fifteen-year-old boy, I did not want to visit the doctor. However, as a student very interested in biology, I realized that eye problems, as with most health problems, could become more complicated if not treated early in development. Thus, my mother and I went to the ophthalmologist, concerned that I might have some sort of glaucoma or cataract. I was told that I had iritis. I remember thinking ûWhew, it was nothing major.”
Uveitis, also known as intraocular inflammation, is a prototypical illness that begs for collaboration. Uveitis is often best assessed and optimally treated by an inter-disciplinary team. In this review, we seek to prepare rheumatologists with information that can facilitate the success of this collaborative effort.
It is traditional to subdivide uveitis into anterior uveitis (or iridocyclitis) and posterior uveitis (or choroiditis), but it is only convenient to retain this concept if it can contribute a better understanding of the causes
Traumatic uveitis patients tend to be young and male and present with unilateral disease, and tend to have better visual outcomes than patients in the nontraumatic uveitis cohort. In spite of relatively good visual outcomes, the traumatic uveitis patients still experienced a high burden of disease, measured both in number of clinic visits and duration of follow-up.
Uveitis responds to treatment, clears up without recurrence, and usually impacts the anterior part of the eye. Chronic uveitis more regularly affects the intermediate and posterior uvea, and it can be more resistant to treatment. (Learn More) Chronic uveitis can have a multitude of causes, such as infection or systemic inflammatory disease.
Uveitis describes inflammation that exists in the uveal tract, but the disease course has such a variety of manifestations, iterations and presentations that no simple one-size-fits-all depiction may be appropriate.
Rarely has a field of medicine been more challenging than the field of intraocular inflammation. The study of uveitic entities presents great challenges to the treating ophthalmologists because the list of differential diagnosis ever grows to encompass a range of diseases from infectious to immunological to malignant.
The effects of uveitis are life changing, causing vision damage and even blindness. However, early detection and effective treatment can halt inflammation and protect patients from permanent eye damage and vision loss.
“Uveitis appears to increase with increasing age in most studies,” she said. “Visual morbidity is significant in patients with uveitis but may be underreported because uveitis is often not listed as a cause of visual loss in global assessments of blindness.”
Uvea-WHAT? . . . “Uveitis” . . . I have what? “U’VE-I-TIS. It is an inflammation of your UVEAL tract” . . . What? . . . “UVEA. The middle layer of your eye” Dr. Foster explained patiently. “The middle layer of the eye, between the sclera and retina, is called the uvea. When the uvea becomes inflamed, the condition is called uveitis.” He changed my medications around.
Interested in Uveitis Research Studies?
Our mission is to find cures for ocular inflammatory diseases, to erase the worldwide deficit of properly trained ocular immunologists, and to provide education and emotional support for those patients afflicted with ocular inflammatory diseases.
Uveitis refers to a group of inflammatory diseases of the eye, responsible for up to 20% of all blindness. The mission of the American Uveitis Society is to increase, promote, and disseminate knowledge regarding uveitis and to develop and promote research and investigation in the field.
Uveitis is a general term describing a group of inflammatory diseases that produces swelling and destroys eye tissues. These diseases can slightly reduce vision or lead to severe vision loss. The term “uveitis” is used because the diseases often affect a part of the eye called the uvea. Nevertheless, uveitis is not limited to the uvea. These diseases also affect the lens, retina, optic nerve, and vitreous, producing reduced vision or blindness.
Uveitis is an inflammation of the uvea (or uveal layer) – the middle layer of three that make up the eye. It may be infectious or noninfectious. It is a treatable condition; however, without proper treatment, it can lead to other complications including glaucoma, cataracts, optic nerve damage, retinal detachment and severe vision loss.
Various terms are used for the condition, depending on the part of the uvea affected...
Non-infectious uveitis (NIU) is an immune-mediated disease with clinical symptoms such as eye pain, redness, floaters, and light sensitivity. NIU is one of the leading causes of preventable blindness.
Uveitis is defined as inflammation of the uveal tract, which is classically composed of the iris, ciliary body, and choroid, and is an important cause of blindness of young and middle-aged individuals in the world.